Futura Medical (FUM)

 

FUM Share PerformanceMore

52 week high95.60 08/09/16
52 week low14.31 10/05/16
52 week change 32.25 (138.71%)
4 week volume5,256,795 26/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Futura Medical schedules FY results

Futura Medical, the innovative healthcare company focused on advanced transdermal technology, will announce its prelim...

Notice of Preliminary Results

RNS Number: 8686U Futura Medical PLC 23 January 2017 For immediate release 23 January 2017 Futura Medical plc ("Futura" or "the Company") Notice of Preliminary Results Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its preliminary results for the year ended 31 December 20...

Director's dealings

RNS Number: 5373U Futura Medical PLC 18 January 2017 For immediate release 18 January 2017 Futura Medical plc ("Futura" or the "Company") Director's dealings Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has today received notification that James Barder, the Chief Execu...

Director / PDMR Dealing and Grant of Options

RNS Number: 1848U Futura Medical PLC 13 January 2017 13 January 2017 Futura Medical plc ("Futura" or "the Company") Director / PDMR Dealing and Grant of Options Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 13 January 2017 it granted options over a total of 950,000 ord...

Director Deals - Futura Medical PLC (FUM)

James Barder, Chief Executive Officer, exercised 250,000 shares in the company on the 12th January 2017 at a price of 40.5...

Director Deals - Futura Medical PLC (FUM)

Derek Martin, Financial Director, sold post-exercise 250,000 shares in the company on the 12th January 2017 at a price of 55...

Director Deals - Futura Medical PLC (FUM)

James Barder, Chief Executive Officer, sold post-exercise 210,000 shares in the company on the 12th January 2017 at a price...

Director Deals - Futura Medical PLC (FUM)

Derek Martin, Financial Director, exercised 100,000 shares in the company on the 12th January 2017 at a price of 40.50p. Th...

Fundamental DataMore

EPS-5.13
Dividend yield0 %

Equity Research (FUM)

hardman & co
Futura Medical plc
25/11/2015
FUM has advanced transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. 2015 was expected to be a busy year for...
hardman & co
Futura Medical plc
09/09/2015
Futura Medical has advanced transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. 2015 was expected to be a busy...
hardman & co
Futura Medical plc
14/07/2015
Futura Medical has proprietary transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. Headline results from a...

Latest discussion posts More

  • Re: Europe soon ?

    Yes, I have to say James has been excellent over the years regarding investor relations, answering questions promptly. Even in the dark days when Reckitts were in control he ...
    19-Feb-2017
    TonyDeadeye
  • Re: Europe soon ?

    To his credit, Mr Barder has always been very responsive to questions from private investors. In my experience he has always given a definitive answer apart from when his ...
    18-Feb-2017
    oilovlam
  • Europe soon ?

    From another board RE: Message from James BarderToday 13:33Great thanks Chariot for the update. As I suspect this may take off without warning. Reply | Recommend | ...
    17-Feb-2017
    coldascheese

Users' HoldingsMore

Users who hold Futura Medical also hold..
LLOYDS GRP.19%
SIRIUS MINERALS16%
BP13%
BARCLAYS11%
TESCO10%

Codes & Symbols

ISINGB0033278473
SymbolsFUM, LSE:FUM, FUM.L, FUM:LN, LON:FUM, XLON:FUM